The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant

NCT02967055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2020-08-11

Study results available
· View outcomes & findings →

Summary

This exploratory study will fill a knowledge gap regarding the pharmacokinetic effects of isotretinoin on the etonogestrel (ENG) contraceptive implant.

Conditions

  • Contraception

Sponsors & Collaborators

Principal Investigators

  • Aaron Lazorwitz, MD · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2019-04-28
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02967055 on ClinicalTrials.gov